Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Int J Mol Sci ; 24(3)2023 Jan 18.
Artículo en Inglés | MEDLINE | ID: mdl-36768196

RESUMEN

Environmental factors, including westernised diets and alterations to the gut microbiota, are considered risk factors for inflammatory bowel diseases (IBD). The mechanisms underpinning diet-microbiota-host interactions are poorly understood in IBD. We present evidence that feeding a lard-based high-fat (HF) diet can protect mice from developing DSS-induced acute and chronic colitis and colitis-associated cancer (CAC) by significantly reducing tumour burden/incidence, immune cell infiltration, cytokine profile, and cell proliferation. We show that HF protection was associated with increased gut microbial diversity and a significant reduction in Proteobacteria and an increase in Firmicutes and Clostridium cluster XIVa abundance. Microbial functionality was modulated in terms of signalling fatty acids and bile acids (BA). Faecal secondary BAs were significantly induced to include moieties that can activate the vitamin D receptor (VDR), a nuclear receptor richly represented in the intestine and colon. Indeed, colonic VDR downstream target genes were upregulated in HF-fed mice and in combinatorial lipid-BAs-treated intestinal HT29 epithelial cells. Collectively, our data indicate that HF diet protects against colitis and CAC risk through gut microbiota and BA metabolites modulating vitamin D targeting pathways. Our data highlights the complex relationship between dietary fat-induced alterations of microbiota-host interactions in IBD/CAC pathophysiology.


Asunto(s)
Colitis , Enfermedades Inflamatorias del Intestino , Neoplasias , Ratones , Animales , Vitamina D/metabolismo , Inflamación/metabolismo , Colitis/metabolismo , Enfermedades Inflamatorias del Intestino/metabolismo , Colon/patología , Dieta Alta en Grasa/efectos adversos , Bacterias , Ácidos y Sales Biliares/metabolismo , Ratones Endogámicos C57BL , Sulfato de Dextran/efectos adversos , Neoplasias/metabolismo
2.
Gut ; 63(12): 1913-20, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25021423

RESUMEN

OBJECTIVE: The commensal microbiota, host immunity and metabolism participate in a signalling network, with diet influencing each component of this triad. In addition to diet, many elements of a modern lifestyle influence the gut microbiota but the degree to which exercise affects this population is unclear. Therefore, we explored exercise and diet for their impact on the gut microbiota. DESIGN: Since extremes of exercise often accompany extremes of diet, we addressed the issue by studying professional athletes from an international rugby union squad. Two groups were included to control for physical size, age and gender. Compositional analysis of the microbiota was explored by 16S rRNA amplicon sequencing. Each participant completed a detailed food frequency questionnaire. RESULTS: As expected, athletes and controls differed significantly with respect to plasma creatine kinase (a marker of extreme exercise), and inflammatory and metabolic markers. More importantly, athletes had a higher diversity of gut micro-organisms, representing 22 distinct phyla, which in turn positively correlated with protein consumption and creatine kinase. CONCLUSIONS: The results provide evidence for a beneficial impact of exercise on gut microbiota diversity but also indicate that the relationship is complex and is related to accompanying dietary extremes.


Asunto(s)
Dieta/efectos adversos , Proteínas en la Dieta/metabolismo , Ejercicio Físico/fisiología , Tracto Gastrointestinal/microbiología , Microbiota/fisiología , Deportes/fisiología , Adulto , Biomarcadores/metabolismo , Índice de Masa Corporal , Creatina Quinasa/sangre , Análisis de los Alimentos , Humanos , Inmunidad/fisiología , Inflamación/metabolismo , Masculino , Fenómenos Fisiológicos en la Nutrición Deportiva
3.
Gut ; 62(2): 220-6, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22345653

RESUMEN

OBJECTIVE: The gut microbiota is an environmental regulator of fat storage and adiposity. Whether the microbiota represents a realistic therapeutic target for improving metabolic health is unclear. This study explored two antimicrobial strategies for their impact on metabolic abnormalities in murine diet-induced obesity: oral vancomycin and a bacteriocin-producing probiotic (Lactobacillus salivarius UCC118 Bac(+)). DESIGN: Male (7-week-old) C57BL/J6 mice (9-10/group) were fed a low-fat (lean) or a high-fat diet for 20 weeks with/without vancomycin by gavage at 2 mg/day, or with L. salivarius UCC118Bac(+) or the bacteriocin-negative derivative L. salivarius UCC118Bac(-) (each at a dose of 1×10(9) cfu/day by gavage). Compositional analysis of the microbiota was by 16S rDNA amplicon pyrosequencing. RESULTS: Analysis of the gut microbiota showed that vancomycin treatment led to significant reductions in the proportions of Firmicutes and Bacteroidetes and a dramatic increase in Proteobacteria, with no change in Actinobacteria. Vancomycin-treated high-fat-fed mice gained less weight over the intervention period despite similar caloric intake, and had lower fasting blood glucose, plasma TNFα and triglyceride levels compared with diet-induced obese controls. The bacteriocin-producing probiotic had no significant impact on the proportions of Firmicutes but resulted in a relative increase in Bacteroidetes and Proteobacteria and a decrease in Actinobacteria compared with the non-bacteriocin-producing control. No improvement in metabolic profiles was observed in probiotic-fed diet-induced obese mice. CONCLUSION: Both vancomycin and the bacteriocin-producing probiotic altered the gut microbiota in diet-induced obese mice, but in distinct ways. Only vancomycin treatment resulted in an improvement in the metabolic abnormalities associated with obesity thereby establishing that while the gut microbiota is a realistic therapeutic target, the specificity of the antimicrobial agent employed is critical.


Asunto(s)
Antibacterianos/farmacología , Intestinos/efectos de los fármacos , Obesidad/tratamiento farmacológico , Probióticos/farmacología , Vancomicina/farmacología , Animales , Antibacterianos/administración & dosificación , Bacterias/efectos de los fármacos , Bacteriocinas/administración & dosificación , Bacteriocinas/farmacología , Glucemia/efectos de los fármacos , Dieta Alta en Grasa/efectos adversos , Sistemas de Liberación de Medicamentos , Expresión Génica , Inflamación/sangre , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/microbiología , Intestinos/microbiología , Lactobacillus/fisiología , Masculino , Metagenoma/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , Obesidad/etiología , Obesidad/metabolismo , Obesidad/microbiología , Probióticos/administración & dosificación , Triglicéridos/sangre , Factor de Necrosis Tumoral alfa/sangre , Factor de Necrosis Tumoral alfa/efectos de los fármacos , Factor de Necrosis Tumoral alfa/genética , Vancomicina/administración & dosificación , Aumento de Peso/efectos de los fármacos
5.
Gut Microbes ; 6(2): 131-6, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25800089

RESUMEN

Sedentary lifestyle is linked with poor health, most commonly obesity and associated disorders, the corollary being that exercise offers a preventive strategy. However, the scope of exercise biology extends well beyond energy expenditure and has emerged as a great 'polypill', which is safe, reliable and cost-effective not only in disease prevention but also treatment. Biological mechanisms by which exercise influences homeostasis are becoming clearer and involve multi-organ systemic adaptations. Most of the elements of a modern lifestyle influence the indigenous microbiota but few studies have explored the effect of increased physical activity. While dietary responses to exercise obscure the influence of exercise alone on gut microbiota, professional athletes operating at the extremes of performance provide informative data. We assessed the relationship between extreme levels of exercise, associated dietary habits and gut microbiota composition, and discuss potential mechanisms by which exercise may exert a direct or indirect influence on gut microbiota.


Asunto(s)
Dieta/métodos , Ejercicio Físico , Conducta Alimentaria , Microbioma Gastrointestinal , Microbiota , Atletas , Humanos
6.
PLoS One ; 8(6): e65790, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23762426

RESUMEN

Links between the gut microbiota and host metabolism have provided new perspectives on obesity. We previously showed that the link between the microbiota and fat deposition is age- and time-dependent subject to microbial adaptation to diet over time. We also demonstrated reduced weight gain in diet-induced obese (DIO) mice through manipulation of the gut microbiota with vancomycin or with the bacteriocin-producing probiotic Lactobacillus salivarius UCC118 (Bac(+)), with metabolic improvement achieved in DIO mice in receipt of vancomycin. However, two phases of weight gain were observed with effects most marked early in the intervention phase. Here, we compare the gut microbial populations at the early relative to the late stages of intervention using a high throughput sequencing-based analysis to understand the temporal relationship between the gut microbiota and obesity. This reveals several differences in microbiota composition over the intervening period. Vancomycin dramatically altered the gut microbiota composition, relative to controls, at the early stages of intervention after which time some recovery was evident. It was also revealed that Bac(+) treatment initially resulted in the presence of significantly higher proportions of Peptococcaceae and significantly lower proportions of Rikenellaceae and Porphyromonadaceae relative to the gut microbiota of L. salivarius UCC118 bacteriocin negative (Bac(-)) administered controls. These differences were no longer evident at the later time. The results highlight the resilience of the gut microbiota and suggest that interventions may need to be monitored and continually adjusted to ensure sustained modification of the gut microbiota.


Asunto(s)
Dieta/efectos adversos , Microbiota , Obesidad/microbiología , Animales , Biodiversidad , Recuento de Colonia Microbiana , Tracto Gastrointestinal/efectos de los fármacos , Tracto Gastrointestinal/microbiología , Masculino , Ratones , Ratones Endogámicos C57BL , Microbiota/efectos de los fármacos , Obesidad/patología , Filogenia , Análisis de Componente Principal , Factores de Tiempo , Vancomicina/administración & dosificación , Vancomicina/farmacología , Aumento de Peso/efectos de los fármacos
7.
Gut Microbes ; 4(1): 48-53, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23018760

RESUMEN

Obesity is associated with a number of serious health consequences, including type 2 diabetes, cardiovascular disease and a variety of cancers among others and has been repeatedly shown to be associated with a higher risk of mortality. The relatively recent discovery that the composition and metabolic activity of the gut microbiota may affect the risk of developing obesity and related disorders has led to an explosion of interest in this distinct research field. A corollary of these findings would suggest that modulation of gut microbial populations can have beneficial effects with respect to controlling obesity. In this addendum, we summarize our recent data, showing that therapeutic manipulation of the microbiota using different antimicrobial strategies may be a useful approach for the management of obesity and metabolic conditions. In addition, we will explore some of the mechanisms that may contribute to microbiota-induced susceptibility to obesity and metabolic diseases.


Asunto(s)
Antibacterianos/administración & dosificación , Bacterias/efectos de los fármacos , Tracto Gastrointestinal/microbiología , Obesidad/prevención & control , Animales , Bacterias/clasificación , Modelos Animales de Enfermedad , Ratones , Obesidad/microbiología
8.
Gut Microbes ; 3(3): 186-202, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22572830

RESUMEN

Obesity develops from a prolonged imbalance of energy intake and energy expenditure. However, the relatively recent discovery that the composition and function of the gut microbiota impacts on obesity has lead to an explosion of interest in what is now a distinct research field. Here, research relating to the links between the gut microbiota, diet and obesity will be reviewed under five major headings: (1) the gut microbiota of lean and obese animals, (2) the composition of the gut microbiota of lean and obese humans, (3) the impact of diet on the gut microbiota, (4) manipulating the gut microbiota and (5) the mechanisms by which the gut microbiota can impact on weight gain.


Asunto(s)
Dieta/métodos , Tracto Gastrointestinal/microbiología , Metagenoma/fisiología , Obesidad/microbiología , Animales , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA